Eli Lilly and Company
Patents, Design & Utilities
Last updated:
List of all Eli Lilly and Company patents 385 in total
| Status | Patent |
|---|---|
Grant | Utility: Amino pyrimidine ssao inhibitors Filling date: 18 Sep 2025 Issue date: 6 Oct 2020 |
Application | Utility: MEDICATION DELIVERY SYSTEMS AND METHODS Filling date: 18 Sep 2025 Issue date: 1 Oct 2020 |
Application | Utility: COMBINATION OF ERK1/2 INHIBITOR COMPOUND WITH GEMCITABINE OR WITH GEMCITABINE AND NAB-PACLITAXEL FOR USE IN TREATMENT OF PANCREATIC CANCER Filling date: 18 Sep 2025 Issue date: 1 Oct 2020 |
Grant | Utility: (E)-1-(4-(dimethylamino)but-2-enoyl)pyrrolidin-3-yl 4-((3-isopropyl-5-methylpyrazolo[1,5-a]pyrimidin-7-yl)amino)piperidine-1-- carboxylate for inhibiting CDK7 Filling date: 18 Sep 2025 Issue date: 29 Sep 2020 |
Grant | Utility: 2,6-diamino pyridine compounds Filling date: 18 Sep 2025 Issue date: 22 Sep 2020 |
Grant | Utility: Trigger assembly for automatic medication injection device Filling date: 18 Sep 2025 Issue date: 22 Sep 2020 |
Grant | Utility: Azetidinyloxyphenylpyrrolidine compounds Filling date: 18 Sep 2025 Issue date: 22 Sep 2020 |
Application | Utility: BTK INHIBITOR COMPOUNDS Filling date: 18 Sep 2025 Issue date: 17 Sep 2020 |
Grant | Utility: IgG bispecific antibodies and processes for preparation Filling date: 18 Sep 2025 Issue date: 15 Sep 2020 |
Grant | Utility: Medication delivery systems and methods Filling date: 18 Sep 2025 Issue date: 8 Sep 2020 |
Application | Utility: TUBE MANAGEMENT DEVICE FOR AN INFUSION SET Filling date: 18 Sep 2025 Issue date: 3 Sep 2020 |
Grant | Utility: 1-tetrahydropyranylcarbonyl-2,3-dihydro-1H-indole compounds for treating cancer Filling date: 18 Sep 2025 Issue date: 1 Sep 2020 |
Grant | Utility: Treatment of androgen deprivation therapy associated symptoms Filling date: 18 Sep 2025 Issue date: 1 Sep 2020 |
Application | Utility: Combination Therapy of Lasmiditan and a CGRP Antagonist for Use in the Treatment of Migraine Filling date: 18 Sep 2025 Issue date: 27 Aug 2020 |
Grant | Utility: 6-fluoro 2-methylbenzo[d]thiazol-5-yl compounds Filling date: 18 Sep 2025 Issue date: 25 Aug 2020 |
Application | Utility: ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF Filling date: 18 Sep 2025 Issue date: 20 Aug 2020 |
Application | Utility: THERAPEUTIC ANTIBODY FORMULATION Filling date: 18 Sep 2025 Issue date: 20 Aug 2020 |
Application | Utility: AMINO PYRIMIDINE SSAO INHIBITORS Filling date: 18 Sep 2025 Issue date: 20 Aug 2020 |
Application | Utility: PHARMACEUTICAL COMBINATIONS COMPRISING INSULIN AND AT LEAST AN AGENT SELECTED FROM MELOXICAM, BROMFENAC SODIUM, ACETYLSALICYLIC ACID, SALICYCLIC ACID AND PARACETAMOL Filling date: 18 Sep 2025 Issue date: 20 Aug 2020 |
Application | Utility: KCNQ Potentiators Filling date: 18 Sep 2025 Issue date: 6 Aug 2020 |
Application | Utility: BTLA AGONIST ANTIBODIES AND USES THEREOF Filling date: 18 Sep 2025 Issue date: 30 Jul 2020 |
Application | Utility: TUBING HAVING VISUAL MARKERS FOR VISUALIZATION OF MEDIA THEREIN Filling date: 18 Sep 2025 Issue date: 30 Jul 2020 |
Grant | Utility: Reusable medication delivery device with remaining medication determination capability Filling date: 18 Sep 2025 Issue date: 28 Jul 2020 |
Application | Utility: LYSOPHOSPHATIDIC ACID RECEPTOR 1 (LPAR1) INHIBITOR COMPOUNDS Filling date: 18 Sep 2025 Issue date: 23 Jul 2020 |
Application | Utility: SYSTEM FOR ACCELERATED TESTING OF SILICONE DRAINAGE IN SYRINGES Filling date: 18 Sep 2025 Issue date: 16 Jul 2020 |
Application | Utility: NEEDLE SHIELD PULLER FOR DRUG DELIVERY SYSTEM Filling date: 18 Sep 2025 Issue date: 16 Jul 2020 |
Grant | Utility: Fusion proteins Filling date: 18 Sep 2025 Issue date: 14 Jul 2020 |
Grant | Utility: Compounds and compositions for treating chemical warfare agent-induced injuries Filling date: 18 Sep 2025 Issue date: 7 Jul 2020 |
Application | Utility: DOSE DETECTION MODULE FOR A MEDICATION DELIVERY DEVICE Filling date: 18 Sep 2025 Issue date: 2 Jul 2020 |
Grant | Utility: Mutant IDH1 inhibitors Filling date: 18 Sep 2025 Issue date: 30 Jun 2020 |
Application | Utility: ANTI-ANGPTL 3/8 COMPLEX ANTIBODIES AND METHODS OF USING THE SAME Filling date: 18 Sep 2025 Issue date: 25 Jun 2020 |
Application | Utility: ANTI-ANGPTL 3/8 COMPLEX ANTIBODIES AND METHODS OF USING THE SAME Filling date: 18 Sep 2025 Issue date: 25 Jun 2020 |
Application | Utility: CHEMICALLY DRIVEN AUTO-INJECTOR WITH RETRACTION Filling date: 18 Sep 2025 Issue date: 25 Jun 2020 |
Application | Utility: CLOSED LOOP CONTROL OF PHYSIOLOGICAL GLUCOSE Filling date: 18 Sep 2025 Issue date: 25 Jun 2020 |
Grant | Utility: Combination therapy with Notch and PD-1 or PD-L1 inhibitors Filling date: 18 Sep 2025 Issue date: 23 Jun 2020 |
Application | Utility: INJECTION DEVICE WITH PLUNGER ARRANGMENT AND CONVERGING RAMPS Filling date: 18 Sep 2025 Issue date: 18 Jun 2020 |
Application | Utility: CGRP RECEPTOR ANTAGONISTS Filling date: 18 Sep 2025 Issue date: 11 Jun 2020 |
Application | Utility: INJECTION DEVICE WITH PRIMING ARRANGEMENT Filling date: 18 Sep 2025 Issue date: 11 Jun 2020 |
Application | Utility: DOSE DETECTION MODULE FOR A MEDICATION DELIVERY DEVICE Filling date: 18 Sep 2025 Issue date: 4 Jun 2020 |
Application | Utility: THERAPEUTIC USES OF DULAGLUTIDE Filling date: 18 Sep 2025 Issue date: 4 Jun 2020 |
Grant | Utility: Lock for an automatic injection device Filling date: 18 Sep 2025 Issue date: 2 Jun 2020 |
Grant | Utility: Automatic injection device Filling date: 18 Sep 2025 Issue date: 2 Jun 2020 |
Grant | Utility: Base for an automatic injection device Filling date: 18 Sep 2025 Issue date: 26 May 2020 |
Application | Utility: ANTI-CD137 ANTIBODIES Filling date: 18 Sep 2025 Issue date: 21 May 2020 |
Application | Utility: COMBINATION OF AN ANTIBODY THAT BINDS TO THE P19 SUBUNIT OF HUMAN IL-23 AND A HYALURONIDASE ENZYME Filling date: 18 Sep 2025 Issue date: 21 May 2020 |
Application | Utility: COMBINATIONS OF EGFR INHIBITORS AND ANTI-HUMAN VEGFR-2 ANTIBODIES Filling date: 18 Sep 2025 Issue date: 21 May 2020 |
Application | Utility: Engineered Antibody Compounds and Conjuates Thereof Filling date: 18 Sep 2025 Issue date: 21 May 2020 |
Grant | Utility: Selective estrogen receptor degraders Filling date: 18 Sep 2025 Issue date: 19 May 2020 |
Application | Utility: DOSE DETECTION MODULE FOR A MEDICATION DELIVERY DEVICE Filling date: 18 Sep 2025 Issue date: 14 May 2020 |
Grant | Utility: Anti-N3pGlu amyloid beta peptide antibodies and uses thereof Filling date: 18 Sep 2025 Issue date: 12 May 2020 |
Showing 250 to 300 of 385 patents.